|
2020
|
Invention
|
Targeting nad biosynthesis in the treatment of cancer. inter aliainter alia, methods for treatmen... |
|
2019
|
Invention
|
Compositions and methods for modulating transcriptional activity of amplified oncogenes contained... |
|
2017
|
Invention
|
Modified crispr rna and uses thereof.
The present disclosure provides compounds comprising modif... |
|
|
Invention
|
Modified crispr rna and uses thereof. The present disclosure provides compounds comprising modifi... |
|
|
Invention
|
Methods for modulating expression of c9orf72 antisense transcript. Disclosed herein are compositi... |
|
|
Invention
|
Truncated variant of the mammalian target for rapamycin (mtor) protein.
The invention relates to... |
|
2016
|
Invention
|
Detection of epha3 as a marker of the presence of a solid tumor.
The invention provides methods ... |
|
2015
|
Invention
|
In vivo efficacy of ny-eso-1 plus adjuvant.
The invention relates to the discovery that administ... |
|
2014
|
Invention
|
Methods for modulating expression of c9orf72 antisense transcript.
Disclosed herein are methods ... |
|
|
Invention
|
Methods for modulating expression of c9orf72 antisense transcript. Disclosed herein are methods f... |
|
|
Invention
|
Methods and compositions for cdna synthesis and single-cell transcriptome profiling using templat... |
|
|
Invention
|
Whole-genome and targeted haplotype reconstruction. The present invention relates to methods for ... |
|
|
Invention
|
Methods and compositions for modulation of blood-neural barrier. Methods and compositions for mod... |
|
|
Invention
|
Immunogenic compositions useful in provoking an integrated response to tumor antigens.
The inven... |
|
2013
|
Invention
|
Methods for modulating c9orf72 expression. Disclosed herein are methods for reducing expression o... |
|
|
Invention
|
Targeting vegf-b regulation of fatty acid transporters to modulate human diseases. The present in... |
|
2012
|
Invention
|
Specific binding proteins and uses thereof. The invention relates to specific binding members, pa... |
|
|
Invention
|
Analogs of alpha galactosylceramide and uses thereof. Compounds of formula
wherein the variables... |
|
|
Invention
|
Ctsp cancer-testis antigens. The invention relates to CTSP polypeptides and the nucleic acid mole... |
|
|
Invention
|
Method for modulating activity of t lymphocytes. The invention relates to methods and composition... |
|
|
Invention
|
Method for inducing cell lysis with immunogenic portions of ny-eso-1 protein. The invention relat... |
|
2011
|
Invention
|
A34 and a33-like 3 dna protein, antibodies thereto and methods of treatment using same. Polynucle... |
|
|
Invention
|
Analogs of alpha galactosylceramide and uses thereof. Compounds of formula
wherein the variable ... |
|
|
Invention
|
Mage-c2 antigenic peptides and uses thereof. 2 microglobulin and a first and second binding partn... |
|
|
Invention
|
Detection of epha3 as a marker of the presence of a solid tumor. The disclosure provides methods ... |
|
|
Invention
|
Antibodies directed to the receptor tyrosine kinase c-met. The present invention relates to antib... |
|
2010
|
Invention
|
Specific binding proteins and uses thereof.
The present invention relates to specific binding me... |
|
|
Invention
|
Tame based chelators and uses thereof. New bifunctional chelation complexes are described. These ... |
|
|
Invention
|
Proteins having serine/threonine kinase domains, corresponding nucleic acid molecules, and their ... |
|
|
Invention
|
Fused heteroaryl derivatives. The present invention provides a pharmaceutical composition which i... |
|
|
Invention
|
Human sarcoma-associated antigens. The invention relates to sarcoma-associated antigens and the n... |
|
2009
|
Invention
|
Methods for the treatment of cancer.
Methods for treating cancer with at least one HGF-Met inhib... |
|
|
Invention
|
Regulation of fatty acid transporters.
The present invention provides materials and methods for ... |
|
2008
|
Invention
|
Method for modifying celluar immune resonse by modulating activin activity.
The invention relate... |
|
|
Invention
|
Truncated variant of the mammalian target for rapamycin (mtor) protein. The invention relates to ... |
|
|
Invention
|
Humanized gm-csf antibodies. Chimeric antibodies, as well as fusion proteins which comprise chime... |
|
2007
|
Invention
|
Antibodies which bind specifically to activin receptor like kinase 3. A new receptor family has b... |
|
|
Invention
|
Method for determining presence of cancer in a sample by assaying for expression of ecsa/dppa-2 n... |
|
2005
|
Invention
|
Cancer-testis antigens.
The invention relates to cancer-testis antigens and the nucleic acid mol... |
|
1997
|
Invention
|
Isolated tumor rejection antigen precursor proteins mage-2 and mage-3. The invention relates to a... |
